LOVFF (Cannara Biotech) Liabilities-to-Assets : 0.42 (As of Feb. 2025)

Cannara Biotech Liabilities-to-Assets Chart

Cannara Biotech Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Liabilities-to-Assets	Get a 7-Day Free Trial															0.46	0.45	0.43	0.44	0.42

Competitive Comparison of Cannara Biotech's Liabilities-to-Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannara Biotech's Liabilities-to-Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Cannara Biotech's Liabilities-to-Assets falls into.

Cannara Biotech Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Cannara Biotech's Liabilities-to-Assets Ratio for the fiscal year that ended in Aug. 2024 is calculated as:

Cannara Biotech's Liabilities-to-Assets Ratio for the quarter that ended in Feb. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannara Biotech  (OTCPK:LOVFF) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Cannara Biotech Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech Business Description